Technical Analysis for MTNB - Matinas Biopharma Holdings, Inc.

Grade Last Price % Change Price Change
grade A 1.12 12.00% 0.12
MTNB closed up 12.0 percent on Friday, January 18, 2019, on 1.16 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MTNB trend table...

Date Alert Name Type % Chg
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 1,2,3 Pullback Bullish Bullish Swing Setup 12.00%
Jan 17 Boomer Buy Setup Bullish Swing Setup 12.00%
Jan 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 12.00%
Jan 17 Calm After Storm Range Contraction 12.00%
Jan 17 Upper Bollinger Band Walk Strength 12.00%
Jan 17 Wide Bands Range Expansion 12.00%
Jan 16 180 Bullish Setup Bullish Swing Setup 5.66%

Older signals for MTNB ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in identifying and developing therapeutics for the treatment of serious and life-threatening infections. It is engaged in developing a pipeline of product and development candidates, with an initial focus on serious fungal and bacterial infections. Its cochleate delivery technology platform is designed for the targeted delivery of pharmaceuticals directly to the site of infection or inflammation. Its MAT 2203 is an oral formulation of a spectrum anti-fungal drug called amphotericin B, which uses its cochleate delivery technology. Its MAT2501 is an orally administered, encochleated formulation of the spectrum aminoglycoside antibiotic amikacin, which may be used to treat different types of multidrug-resistant bacteria, including non-tubercular mycobacterial infections (NTM), as well as various multidrug-resistant gram negative and intracellular bacterial infections.
Is MTNB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.48
52 Week Low 0.32
Average Volume 1,565,403
200-Day Moving Average 0.6116
50-Day Moving Average 0.7874
20-Day Moving Average 0.762
10-Day Moving Average 0.9195
Average True Range 0.1111
ADX 35.43
+DI 37.0232
-DI 6.8695
Chandelier Exit (Long, 3 ATRs ) 0.8667
Chandelier Exit (Short, 3 ATRs ) 0.8333
Upper Bollinger Band 1.1323
Lower Bollinger Band 0.3917
Percent B (%b) 0.98
BandWidth 97.191601
MACD Line 0.0892
MACD Signal Line 0.0402
MACD Histogram 0.049
Fundamentals Value
Market Cap 103.01 Million
Num Shares 92 Million
EPS -0.46
Price-to-Earnings (P/E) Ratio -2.43
Price-to-Sales 1705.03
Price-to-Book 10.88
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.35
Resistance 3 (R3) 1.33 1.23 1.31
Resistance 2 (R2) 1.23 1.18 1.24 1.29
Resistance 1 (R1) 1.18 1.14 1.21 1.20 1.28
Pivot Point 1.08 1.08 1.10 1.09 1.08
Support 1 (S1) 1.03 1.03 1.06 1.05 0.96
Support 2 (S2) 0.93 0.99 0.94 0.95
Support 3 (S3) 0.88 0.93 0.93
Support 4 (S4) 0.90